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Of the three DNA ligases present in all vertebrates,
DNA ligase I (Lig1) has been considered essential
for ligatingOkazaki fragments duringDNA replication
and thereby essential for cell viability. Here, we
report the striking finding that a Lig1-null murine
B cell line is viable. Surprisingly, the Lig1-null cells
exhibit normal proliferation and normal immunoglob-
ulin heavy chain class switch recombination and are
not hypersensitive to awide variety of DNAdamaging
agents. These findings demonstrate that Lig1 is not
absolutely required for cellular DNA replication and
repair and that either Lig3 or Lig4 can substitute for
the role of Lig1 in joining Okazaki fragments. The
establishment of a Lig1-null cell line will greatly facil-
itate the characterization of DNA ligase function in
mammalian cells, but the finding alone profoundly
reprioritizes the role of ligase I in DNA replication,
repair, and recombination.
INTRODUCTION
DNA ligases are involved in many aspects of DNA metabolism:
replication, repair, and recombination (Ellenberger and Tomkin-
son, 2008). All eukaryotes have only two or three functional DNA
ligases (I, III, and IV); all are ATP dependent. DNA ligases I (Lig1)
and IV (Lig4) are conserved in all eukaryotes, whereas DNA
ligase III (Lig3) is found only in vertebrates. The functions of these
ligases have been studied for decades. It is generally believed
that the primary function of Lig1 is to join Okazaki fragments dur-
ing DNA replication. Lig3 (in complex with X-ray cross-comple-
mentation protein 1, XRCC1), is thought to be the primary ligase
for DNA excision repair. Lig4 (in complex with XRCC4 and
XRCC4-like factor, XLF) functions exclusively in the nonhomolo-
gous end-joining (c) pathway that repairs DNA double-strand
breaks (DSBs).
Deletion of any of the three ligase genes is incompatible with
mouse embryonic development (Frank et al., 2000; Petrini
et al., 1995; Puebla-Osorio et al., 2006). In contrast, human or
mouse cell lines lacking Lig4 are viable (Grawunder et al.,
1998; Han and Yu, 2008). Recently, deletion of Lig3 in mouse316 Cell Reports 7, 316–320, April 24, 2014 ª2014 The Authorsembryonic stem cells (ESCs) was achieved by introducing a
transgene encoding a mitochondria-targeted ligase, providing
convincing evidence that the mitochondrial function of Lig3 is
essential for cell viability, but its nuclear function is not (Simsek
et al., 2011). Interestingly, Lig3-deficient cells are not hypersen-
sitive to various DNA damaging agents. This unexpected finding
calls into question the role of Lig3 in nuclear DNA repair, which
was largely inferred from its interaction with XRCC1. It is possible
that either Lig3 is not the primary ligase that functions in DNA
excision repair, or that its function in DNA repair can be efficiently
substituted by another ligase (e.g., Lig1). Thus, establishing a
mammalian cell line that lacks Lig1 would be essential for clari-
fying the relative priority of the three ligases in various DNA trans-
actions. Here, we report a Lig1-null mammalian cell line, which
itself permits us to gain insight into its role in DNA repair, replica-
tion, and recombination.RESULTS AND DISCUSSION
Lig1 was previously reported to be essential for the viability of
mouse ESCs (Petrini et al., 1995). In light of a recent report that
Lig1-deficient chicken DT40 cells are viable (Arakawa et al.,
2012), we set forth to test the hypothesis that the cellular lethality
caused by Lig1 deficiency is cell type specific. Gene targeting of
Lig1 was performed in a mouse B cell line (CH12F3) that is
capable of cytokine-induced class switch recombination (CSR)
in vitro. The targeted deletion removes exons 18–19 of the Lig1
gene and causes a frameshift of all downstream exons (Fig-
ure 1A). The resulting mutant allele is very similar to that
described in the previous study that demonstrated an essential
role for Lig1 in mouse ESCs (Petrini et al., 1995). Successful
gene targeting was confirmed by Southern blot analysis (Fig-
ure 1B). CH12F3 cell line has two alleles for Lig1, so two rounds
of gene targeting were performed. Northern blot analysis of
polyadenylated RNA isolated from Lig1P/D cells showed two
mRNA species derived from the two targeted alleles, respec-
tively (Figure 1C). The transcript derived from the P allele is rela-
tively abundant, and its size indicates polyadenylation at the
SV40 polyadenylation signal from the integrated puro cassette
(Figure 1A). The transcript derived from the D allele is of very
low abundance (Figure 1C), and its size is consistent with a tran-
script lacking exon 18–19 (Figure 1A). The low abundance of this
transcript may be due to nonsense-mediated mRNA decay.
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Figure 1. Gene Targeting of Lig1 in CH12F3 Cell Line
(A) Genomic organization of the wild-type and targeted Lig1 allele. The map is drawn to scale. Exons are indicated by numbered boxes. Arrows indicate tran-
scription orientations of expression cassettes of the puromycin-resistant gene (Puro) and diphtheria toxin A chain (DTA), respectively. B, BamHI restriction sites.
Probes used in Southern blot analysis are depicted at the top. A ‘‘+’’ sign indicates the wild-type allele. ‘‘P’’ and ‘‘D’’ indicate targeted alleles with or without the
Puro cassette, respectively. Triangles indicate loxP sites.
(B) Southern blot analysis of BamHI-digested genomic DNA from wild-type (+/+) and targeted cells (+/P, +/D, P/D). Genotypes, sizes of bands, and probes are
indicated.
(C) Northern blot analysis of polyadenylated RNA. The entire Lig1 coding region sequence was used as a probe. The blot was stripped and stored for a month to
allow radioisotype decay before reprobed with b-actin.
(D) Western blot analysis of the Lig1 protein level in wild-type (+/+), Lig1D/D andmouse Lig1 cDNA complemented Lig1D/D cells (D/D+Lig1) with a rabbit polyclonal
antibody raised against GST-Lig1 protein (Proteintech 18051-1-AP). The blot was stripped and reprobed with a Lig3 antibody (BD Biosciences, 611876) and Lig4
antibody (Han et al., 2012), respectively, for loading control and protein size distinction.
(E) Adenylation of Lig1 in the cell extract with a-32P-ATP.When mRNA from Lig1D/D cells (Figure S1A) were analyzed, only
the low-abundance mRNA lacking exons 18–19 were detected
(Figure S1B). RT-PCR using primers at the beginning and end
of the Lig1 coding region sequences yields a barely detectable
smaller-sized band from the Lig1D/D cells (Figure S1C), but not
from the Lig1P/D cells, suggesting that the P-allele-derived tran-
script interferes with RT-PCR. Sanger sequencing of the RT-
PCR product confirmed the absence of exons 18–19 in the
residual mRNA derived from the D allele (Figure S1D). Neither
of the transcripts support Lig1 protein synthesis as was shown
by immunoblotting using two different antibodies that recognize
different regions of Lig1 (Figures 1D and S1E). Finally, adenyla-
tion of Lig1 with a-32P-ATP in cell extract yields a radioactive
band (130 kDa, Figure 1E) matching the size of Lig1 (Figure 1D),
whereas Lig3 and Lig4 migrates at 100 kDa (Figure 1D). The
radioactive band is absent in the extract prepared from Lig1D/D
cells but reappears when Lig1D/D cells were transiently trans-fected with a expression vector carrying mouse Lig1 cDNA (Fig-
ure 1E). Adenylation of Lig3 or Lig4 was not detected under this
assay condition. Based on these data, we conclude that the
gene targeting generated null alleles on both chromosomes in
Lig1P/D and Lig1D/D cells.
Lig1-null CH12F3 cells display a normal proliferative capacity,
with or without cytokine stimulation (Figure 2A). Lig1-null cells
also do not show increased sensitivity to a variety of DNA
damaging agents, including zeocin, cisplatin, hydroxyurea,
camptothecin, but are slightly more sensitive tomethyl methane-
sulfonate (Figure 2B), perhaps suggesting a redundant role for
Lig1 in base excision repair. Cytogenetic analysis of Lig1-null
cells reveals a stable near-diploid karyotype similar to that of
the parental line (Figure 3). For the particular clone used in this
study, a chromosomal rearrangement involving chromosome 1
was identified (Figure 3), but this rearrangement is stably trans-
mitted to progeny cells; no obvious genomic instability hasCell Reports 7, 316–320, April 24, 2014 ª2014 The Authors 317
Figure 2. Proliferation and Drug Sensitivity of Lig1-Null CH12F3 Cells
(A) Live cell counts of wild-type (WT) and Lig1-null (P/D) cells in cultures with (stimulated) or without (unstimulated) cytokines (see Experimental Procedures) for
inducing CSR.
(B) Sensitivity of wild-type (WT) and Lig1-null (D/D) cells to several DNA damaging agents. Error bars represent SEM of three independent experiments.been observed in Lig1-null CH12F3 cells. Because Lig1 and Lig3
have been implicated in joining CSR-associated DSB in NHEJ-
deficient cells, we measured CSR in Lig1-null cells and found
that CSR is not reduced in the absence of Lig1 (Figure 4). No dif-
ference was observed between Lig1P/D and Lig1D/D cells with
regard to cell proliferation, drug sensitivities, and CSR.
Lig1 is conserved throughout evolution and generally consid-
ered indispensable for cell viability due to its well-characterized
role in DNA replication. Although in one previous study, viable
cells were obtained upon targeting exons 23–27 of the Lig1
gene (Bentley et al., 1996, 2002), there is some uncertainty
whether the gene targeting strategy generated a hypomorphic
allele because the catalytic region (e.g., active site K583 in
exon 18) was not removed (Ellenberger and Tomkinson, 2008).
In fact, in another study, deletion of the catalytic domain of
Lig1 was found to be lethal in mouse ESCs (Petrini et al.,
1995). The lack of phenotype upon disrupting the Lig1 gene in
CH12F3 cell line was unexpected but is consistent with a recent
report that Lig1 deletion is compatible with viability in chicken
DT40 cells (Arakawa et al., 2012). Thus, although all three DNA
ligases are essential for mouse embryogenesis, none of them
is absolutely required for somatic cell growth.318 Cell Reports 7, 316–320, April 24, 2014 ª2014 The AuthorsLymphocyte antigen receptor gene rearrangements, including
V(D)J and class switch recombination, require the generation
and repair of programmed DNA DSBs (Alt et al., 2013). Normally,
these DSBs are repaired by the ubiquitous NHEJ pathway that is
dependent on the ligase complex XRCC4/Lig4. However, CSR
can occur in NHEJ-deficient cells at a reduced level via a poorly
defined mechanism often termed alternative end-joining (A-EJ)
(Boboila et al., 2010a, 2010b; Han and Yu, 2008; Yan et al.,
2007). In Lig4-null cells, A-EJ must be mediated by Lig1 and/or
Lig3. Initially, Lig3 (in complex with XRCC1) was thought be
the primary ligase that functions in A-EJ. However, it was
recently shown that neither a substantial depletion of Lig3 by
small hairpin RNA (Boboila et al., 2012), nor ablation of XRCC1
gene in Lig4 or XRCC4 deficient cells inhibits A-EJ during CSR
(Boboila et al., 2012; Han et al., 2012). These data imply that
Lig1 may play a significant role in A-EJ during CSR. Because
Lig1 deficiency alone does not inhibit CSR, these data suggest
either (1) that Lig1 and Lig3 function interchangeably during
A-EJ (Paul et al., 2013), or (2) that Lig1 or Lig3-mediated A-EJ
only contributes to CSR when NHEJ is compromised. A defini-
tive answer to that awaits targeted disruption of Lig1 or Lig3
gene in Lig4-null cells.
Figure 3. A Metaphase of Lig1-Null Cell
All the abnormal chromosomes, two copies of the normal chromosome 14,
and the sex chromosome are as marked. The der(1) is the only abnormality
(marked with solid arrowhead) in comparison with the parental cells, which has
a chromosome count of 41.EXPERIMENTAL PROCEDURES
Reagents
Lig1 antibody (18051-1-AP) was purchased from Proteintech Group. Lig1 (sc-
20222) and b-actin (sc-47778) antibodies were purchased from Santa Cruz
Biotechnology. Primers for amplifying Lig1 coding region sequences, Lig1F
50 ATGAGAAAAAAAGAGCAAGAGAGG 30 and Lig1R 50 TTAATAGTCTTCAA
CGTCGGAGT 30 were purchased Sigma-Aldrich.
Cell Culture and CSR Assay
CH12F3 cells were cultured in RPMI1640 medium supplemented with 10%
fetal bovine serum and 50 mM of beta-mercaptoethanol. For CSR assay,
healthy CH12F3 cells were seeded at 5 3 104 cells/ml in the presence of
1 mg/ml anti-CD40 (eBioscience 16-0402-86), 5 ng/ml of IL-4 (R&D Systems
404-ML), and 0.5 ng/ml TGF-b1 (R&D Systems 240-B) and grown for 72 hr.
Cells were stained with a FITC-conjugated anti-mouse IgA (BD Biosciences
559354) and analyzed on a LSR II flow cytometer (BD Biosciences). CSR effi-
ciency is determined as the percentage of IgA-positive cells.
Lig1 Gene Targeting
Two 2 kb DNA fragments were PCR amplified from CH12F3 genomic DNA
and cloned into a targeting vector as homology blocks for gene targeting
(Figure 1A). Gene targeting procedures have been described previously
(Han and Yu, 2008). Five targeted clones (+/P) were obtained from 192
puromycin resistant clones screened. One of them was randomly picked
for Puro cassette excision and second round of gene targeting. Three
Lig1-null clones were obtained in the second round of gene targeting
from more than 20 targeted clones. One of them was picked for further
studies.
Drug Sensitivity and MTT Assay
Cells were seeded at 1 3 105/ml per well in a 24-well plate, and various drugs
were added at different concentrations. After 48 hr of growth, cell viability was
determined by a colorimetric assay that measures the metabolic conversion ofthiazolyl blue tetrazolium bromide (MTT) in the mitochondria of living cells as
described previously (Han and Yu, 2008).
Adenylation Assay
Twenty million cells were resuspended in 500 ml of adenylation assay
buffer (60 mM Tris Cl, 10 mM MgCl2, 5 nM DTT, 5 mg/ml BSA) and lysed
by three cycles of freezing and thawing. The cell lysate was centrifuged at
21,000 3 g for 15 min at 4C. The supernatant (cell extract) was transferred
to a different tube, and protein concentration was determined by the Bradford
method (Bio-Rad). For the adenylation assay, 6 mg of cell extract was incu-
bated with 10 mCi of a-32P-ATP (3,000 Ci/mmol) in a total volume of 10 ml in
adenylation buffer for 15 min at room temperature. The reaction mixture was
resolved on an 8% SDS-PAGE gel and imaged on a Typhoon 9200 phos-
phoimager (GE Healthcare).
Karyotype of Metaphase Chromosomes
Proliferating cells were harvested for cytogenetic analysis with G banding
using the standard method (Hsieh, 1997).
SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure and can be found with this
article online at http://dx.doi.org/10.1016/j.celrep.2014.03.024.
AUTHOR CONTRIBUTIONS
L.H. performed the gene targeting and Southern and northern blot analysis.
S.M. performed ligase adenylation, cell proliferation, drug sensitivity, and
class-switch assays. C.-l.H. performed the karyotype analysis. K.Y. designed
and supervised all experiments and wrote the manuscript.
ACKNOWLEDGMENTS
This work is supported by a National Institutes of Health grant (R01 AI081817)
to K.Y.
Received: February 18, 2014
Revised: March 6, 2014
Accepted: March 7, 2014
Published: April 10, 2014
REFERENCES
Alt, F.W., Zhang, Y., Meng, F.L., Guo, C., and Schwer, B. (2013). Mechanisms
of programmed DNA lesions and genomic instability in the immune system.
Cell 152, 417–429.
Arakawa, H., Bednar, T., Wang, M., Paul, K., Mladenov, E., Bencsik-Theilen,
A.A., and Iliakis, G. (2012). Functional redundancy between DNA ligases I
and III in DNA replication in vertebrate cells. Nucleic Acids Res. 40, 2599–2610.
Bentley, D., Selfridge, J., Millar, J.K., Samuel, K., Hole, N., Ansell, J.D., and
Melton, D.W. (1996). DNA ligase I is required for fetal liver erythropoiesis but
is not essential for mammalian cell viability. Nat. Genet. 13, 489–491.
Bentley, D.J., Harrison, C., Ketchen, A.M., Redhead, N.J., Samuel, K., Water-
fall, M., Ansell, J.D., and Melton, D.W. (2002). DNA ligase I null mouse cells
show normal DNA repair activity but altered DNA replication and reduced
genome stability. J. Cell Sci. 115, 1551–1561.
Boboila, C., Jankovic, M., Yan, C.T., Wang, J.H., Wesemann, D.R., Zhang, T.,
Fazeli, A., Feldman, L., Nussenzweig, A., Nussenzweig, M., and Alt, F.W.
(2010a). Alternative end-joining catalyzes robust IgH locus deletions and trans-
locations in the combined absence of ligase 4 and Ku70. Proc. Natl. Acad. Sci.
USA 107, 3034–3039.
Boboila, C., Yan, C., Wesemann, D.R., Jankovic, M., Wang, J.H., Manis, J.,
Nussenzweig, A., Nussenzweig, M., and Alt, F.W. (2010b). Alternative end-
joining catalyzes class switch recombination in the absence of both Ku70
and DNA ligase 4. J. Exp. Med. 207, 417–427.Cell Reports 7, 316–320, April 24, 2014 ª2014 The Authors 319
Figure 4. CSR of Lig1-Null CH12F3 Cells
Representative FACS analysis of CSR by surface staining of IgA after 72 hr of growth with (stimulated) or without (unstimulated) cytokines (see the Experimental
Procedures). Numbers in the boxed areas indicate percentages.Boboila, C., Oksenych, V., Gostissa, M., Wang, J.H., Zha, S., Zhang, Y., Chai,
H., Lee, C.S., Jankovic, M., Saez, L.M., et al. (2012). Robust chromosomal
DNA repair via alternative end-joining in the absence of X-ray repair cross-
complementing protein 1 (XRCC1). Proc. Natl. Acad. Sci. USA 109, 2473–
2478.
Ellenberger, T., and Tomkinson, A.E. (2008). Eukaryotic DNA ligases: structural
and functional insights. Annu. Rev. Biochem. 77, 313–338.
Frank, K.M., Sharpless, N.E., Gao, Y., Sekiguchi, J.M., Ferguson, D.O., Zhu,
C., Manis, J.P., Horner, J., DePinho, R.A., and Alt, F.W. (2000). DNA ligase
IV deficiency in mice leads to defective neurogenesis and embryonic lethality
via the p53 pathway. Mol. Cell 5, 993–1002.
Grawunder, U., Zimmer, D., Fugmann, S., Schwarz, K., and Lieber, M.R.
(1998). DNA ligase IV is essential for V(D)J recombination and DNA double-
strand break repair in human precursor lymphocytes. Mol. Cell 2, 477–484.
Han, L., and Yu, K. (2008). Altered kinetics of nonhomologous end joining and
class switch recombination in ligase IV-deficient B cells. J. Exp. Med. 205,
2745–2753.
Han, L., Mao, W., and Yu, K. (2012). X-ray repair cross-complementing protein
1 (XRCC1) deficiency enhances class switch recombination and is permissive
for alternative end joining. Proc. Natl. Acad. Sci. USA 109, 4604–4608.320 Cell Reports 7, 316–320, April 24, 2014 ª2014 The AuthorsHsieh, C.L. (1997). Basic Cytogenetic Techniques: Culture, Slidemaking
and Banding. Cell Biology: A Laboratory Handbook (New York: Academic
Press).
Paul, K., Wang, M., Mladenov, E., Bencsik-Theilen, A., Bednar, T., Wu, W.,
Arakawa, H., and Iliakis, G. (2013). DNA ligases I and III cooperate in alternative
non-homologous end-joining in vertebrates. PLoS ONE 8, e59505.
Petrini, J.H., Xiao, Y., andWeaver, D.T. (1995). DNA ligase I mediates essential
functions in mammalian cells. Mol. Cell. Biol. 15, 4303–4308.
Puebla-Osorio, N., Lacey, D.B., Alt, F.W., and Zhu, C. (2006). Early embryonic
lethality due to targeted inactivation of DNA ligase III. Mol. Cell. Biol. 26, 3935–
3941.
Simsek, D., Furda, A., Gao, Y., Artus, J., Brunet, E., Hadjantonakis, A.K., Van
Houten, B., Shuman, S., McKinnon, P.J., and Jasin, M. (2011). Crucial role for
DNA ligase III in mitochondria but not in Xrcc1-dependent repair. Nature 471,
245–248.
Yan, C.T., Boboila, C., Souza, E.K., Franco, S., Hickernell, T.R., Murphy, M.,
Gumaste, S., Geyer, M., Zarrin, A.A., Manis, J.P., et al. (2007). IgH class
switching and translocations use a robust non-classical end-joining pathway.
Nature 449, 478–482.
